Cell Matters Competitors and Similar CompaniesClear all
Eleven Tx's competitors and similar companies include Pluri Biotech and EdiGENE.
 Eleven Tx Eleven Therapeutics is a biotechnology company focused on using ribonucleic acid interference (RNAi) for nucleic acid therapeutics. |  Pluri Biotech Pluri Biotech (פלורי ביוטק בע"מ, formerly Pluristem Therapeutics) is a clinical-stage biotherapy company developing cell therapies. |  EdiGENE EdiGENE is a biotech company that develops therapeutics using its proprietary technology CRISPR-GNDM (guide nucleotide-directed modulation). | |
Founding Date | Founding Date 2020 | Founding Date 2003 | Founding Date 2015 |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations Tel Aviv-Yafo, IL HQ Cambridge, GB Boston, US | Locations Haifa, IL HQ Potsdam, DE | Locations Cambridge, US HQ |
Employees | Employees 29 | Employees 106 | Employees 49 |
Funding | |||
Latest funding round | Latest funding round $ 22m (almost 4 years ago) | Latest funding round N/A | Latest funding round $ 22m (about 5 years ago) |
Total funding raised | Total funding raised $ 22m | Total funding raised $ 78.4m | Total funding raised $ 143.5m |
For sources of this data, please see the company profile
View Company Profiles
Pluri Biotech
HQ
Haifa, IL
Employees
106
Pluri Biotech (פלורי ביוטק בע"מ, formerly Pluristem Therapeutics) is a clinical-stage biotherapy company developing cell therapies.
View companyEdiGENE
HQ
Cambridge, US
Employees
49
EdiGENE is a biotech company that develops therapeutics using its proprietary technology CRISPR-GNDM (guide nucleotide-directed modulation).
View company